Double-Digit Revenue and EBITDA Growth
Consolidated revenue grew by 13% to $129.1 million and adjusted EBITDA increased by 55% to $15 million, driven by strong performance of core holdings and reduction in selling, general and administrative expenses.
Strategic Review and Settlement with Mithaq
A strategic review committee was formed to unlock shareholder value, and a settlement was reached with the largest shareholder, Mithaq, aligning on strategic focus and adding Mithaq's nominees to the Board.
Bozzetto's Revenue Growth
Bozzetto generated revenue of $86 million, up 13% year-over-year, driven by contributions from the StarChem acquisition and strong demand in Asia.
Cortland Revenue Growth
Cortland's revenue grew by 12% to $43.1 million, driven by strong sales in North America, particularly in the oil and gas and agriculture industries.
Improved Liquidity Position
Consolidated cash increased by $7.8 million, ending Q3 with $120.6 million in cash, supported by proceeds from a new financing arrangement and positive cash flow from operating activities.